MCP
Martin Capital Partners’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-67,659
| Closed | -$2.49M | – | 71 |
|
|
2020
Q4 | $2.49M | Sell |
67,659
-26
| -0% | -$957 | 1.46% | 37 |
|
|
2020
Q3 | $2.55M | Sell |
67,685
-911
| -1% | -$34.3K | 1.7% | 30 |
|
|
2020
Q2 | $2.8M | Sell |
68,596
-1,628
| -2% | -$66.4K | 1.97% | 26 |
|
|
2020
Q1 | $2.66M | Sell |
70,224
-1,235
| -2% | -$46.8K | 2.03% | 24 |
|
|
2019
Q4 | $3.36M | Sell |
71,459
-46,602
| -39% | -$2.19M | 1.98% | 27 |
|
|
2019
Q3 | $5.04M | Buy |
118,061
+2,613
| +2% | +$112K | 3.39% | 3 |
|
|
2019
Q2 | $4.62M | Buy |
115,448
+5,598
| +5% | +$224K | 3.27% | 5 |
|
|
2019
Q1 | $4.59M | Buy |
109,850
+15,845
| +17% | +$662K | 3.54% | 4 |
|
|
2018
Q4 | $3.59M | Buy |
94,005
+2,124
| +2% | +$81.2K | 3.31% | 7 |
|
|
2018
Q3 | $3.69M | Buy |
91,881
+2,300
| +3% | +$92.4K | 3.31% | 6 |
|
|
2018
Q2 | $3.61M | Sell |
89,581
-5,206
| -5% | -$210K | 3.69% | 3 |
|
|
2018
Q1 | $3.7M | Buy |
94,787
+6,592
| +7% | +$258K | 3.69% | 4 |
|
|
2017
Q4 | $3.13M | Buy |
+88,195
| New | +$3.13M | 3.25% | 12 |
|